Fischer Medical Ventures' partner wins AI innovation award

Fischer Medical Ventures announced its joint venture partner Nanyang Biologics won first prize at the SuperAI Genesis Startup Competition for AI-driven drug discovery focused on nature-derived compounds.

The company's DTIGN platform demonstrated 25% higher accuracy and 10x faster model training compared to competitors, plus 8x faster molecular docking.

Nanyang Biologics has partnerships with NVIDIA, Johnson & Johnson Innovation, Equinix, and Hewlett Packard Enterprise, and will present at NVIDIA's GTC 2025.